"Drug-Induced Hypothyroidism during Anti-Tuberculosis Treatment of Multidrug-Resistant Tuberculosis: Notes from the Field"
written by Somashekar Munivenkatappa, Singarajipura Anil, Balaji Naik, Tyson Volkmann, Karuna D. Sagili, Jayachamarajapura S. Akshatha, Shashidhar Buggi, Manchenahalli A. Sharada, Sudhendra Kulkarni, Vineet K. Chadha, Patrick K. Moonan,
published by Journal of Tuberculosis Research, Vol.4 No.3, 2016
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Лекарственно-индуцированный гипотиреоз
2020
[2] Safety implications of combined antiretroviral and anti-tuberculosis drugs
2019
[3] Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis
2019
[4] Гипотиреоз у больных туберкулезом, получающих тиоуреидоиминометилпиридиния перхлорат
2018
[5] Pattern of Adverse Effects of Drugs Used To Treat Multi Drug Resistant Tuberculosis
2018
[6] Global epidemiology of hyperthyroidism and hypothyroidism
Nature Reviews Endocrinology, 2018
[7] Effect of antituberculosis treatment on thyroid profile in newly detected smear positive pulmonary tuberculosis cases
2018
[8] Hypothyroidism associated with therapy for multi‐drug resistant tuberculosis in Australia
Internal medicine journal, 2018
[9] Operational research within a Global Fund supported tuberculosis project in India: why, how and its contribution towards change in policy and practice
Global Health Action, 2018
[10] Effect of anti-tuberculosis treatment on thyroid profile in newly detected smear positive pulmonary tuberculosis cases
2018
[11] Endocrine and metabolic aspects of tuberculosis
Microbiol Spectr, 2017
[12] Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: a retrospective study
Medicine, 2017
[13] ВЫПУСКНАЯ КВАЛИФИКАЦИОННАЯ (ДИПЛОМНАЯ) РАБОТА
2017
[14] Hypothyroidism in tuberculosis patients receiving tioureidoiminomethylpyridinium perchlorate therapy
2017